Showing results (31-40 of 244) with videos related to
Sort By:
Pageof 25
Plos One|December 20, 2012
Binding of TCR multimers and a TCR-like antibody with distinct fine-specificities is dependent on the surface density of HLA complexesJianrong L Low, Anneta Naidoo, Gladys Yeo, et al.Journal of Hepatology|December 15, 2010
Engineering virus-specific T cells that target HBV infected hepatocytes and hepatocellular carcinoma cell linesAdam J Gehring, Shao-An Xue, Zi Zong Ho, et al.Hepatology Communications|October 9, 2019
Fine-Tuning TLR-7-Based Therapy for Functional HBV CureAntonio Bertoletti, Nina Le BertSeminars in Liver Disease|June 1, 2017
Clinical Trial Design for Immune-Based Therapy of Hepatitis B VirusUpkar S Gill, Antonio BertolettiCellular & Molecular Immunology|September 2, 2014
The immune tolerant phase of chronic HBV infection: new perspectives on an old conceptAntonio Bertoletti, Patrick T KennedyThe Journal of Clinical Investigation|August 3, 2013
Mobilizing monocytes to cross-present circulating viral antigen in chronic infectionAdam J Gehring, Muzlifah Haniffa, Patrick T Kennedy, et al.Cellular & Molecular Immunology|November 4, 2014
Dissecting the dendritic cell controversy in chronic hepatitis B virus infectionAdam J Gehring, June Ann D'AngeloJournal of Hepatology|April 17, 2016
The role of innate immunity in the immunopathology and treatment of HBV infectionMala K Maini, Adam J GehringCurrent Opinion in Immunology|May 4, 2020
HBV as a target for CAR or TCR-T cell therapyAntonio Bertoletti, Anthony Tanoto TanImmunology and Cell Biology|March 1, 2002
Control or persistence of hepatitis B virus: the critical role of initial host-virus interactionsGeorge Jm Webster, Antonio BertolettiPageof 25